Covid-19测试,药物开发,诊断和设备解决方案

无论您是如何开发Covid-19测定,疫苗,以防止患者获得Covid-19,抗病毒或治疗,以减轻与Covid-19相关的严重免疫应答(细胞因子风暴),我们可以与您携手合作以提供关键药物开发和诊断服务来解决大流行。

Connect with our COVID-19 response team


We're in this Together

Fighting the COVID-19 Pandemic to Make a Difference for Patients

从诊断到交付的发展,我们正在进行使您的速度增加到市场,并加速全球需求的Covid-19治疗方案。了解我们如何共同努力,帮助您实现攻击目标,最终会满足患者的迫切需求。

瞬间Covid-19击中,Labcorp的近65,000名员工开始与创新的测试和治疗解决方案开始对抗病毒。通过重点研究科学,我们在改善患者,提供者和我们的全球社区的结果方面发挥了重要作用。

信息表:开发Covid-19测定疫苗和新型治疗方法的综合解决方案


Together, we can deliver unmatched acceleration. Here’s how we will:

能够与我们的Covid-19回复团队进行高度协作的伙伴关系

A dedicated and highly coordinatedCOVID-19 Response Team将帮助您联系到合适的人员和监管机构,以加快您的发展。

无缝地整合跨功能专长,以满足您的最终开发

在阶段之间快速过渡并消除可能影响您时间表的危险的切换点。当您搬到下阶段时,我们的协调服务的广度扩展了您的团队的科学和医学专业知识,因为您在Covid-19开发旅程的下一阶段移动。

Apply diagnostic insights and proprietary patient data to recruit for clinical studies

Flexibility, nimbleness and unparalleled patient insights are essential for COVID-19 testing and drug development.Refine your recruitment strategieswith unparalleled patient and investigator site data and transformative technologies to enable study design, patient recruitment, forecasting, site selection and study monitoring.


Apply the Labcorp Advantage in the Fight Against COVID-19. No other organization can offer this breadth of coordinated services or match our global reach

#WeAreInThisTogether

Labcorp.独特地定位于与您合作,提供关键的服务,以解决全球Covid-19大流行,以及药物开发和诊断能力的组合。

We're in this together to. . .

  • 通过发展来降低死亡率抗病毒治疗
  • 通过发展来降低死亡率treatments to减轻严重的免疫反应in some patients, i.e., cytokine storm caused during some COVID-19 infections.
  • Prevent people from getting COVID-19 throughvaccine development
  • 提供对患者样品的访问,并根据我们的诊断Covid-19测试(包括超过20%的美国人口)直接访问患者,以评估有活性感染的患者,并确定对病毒的免疫应答。

减少您的学习初期高达50%

大流行危机要求诉讼和研究Covid-19研究的启动加速度。

联系us to know more about how we're accelerating these types of elements to help you get a treatment to market as quickly as possible.

Connect with our COVID-19 Response Team

联系我们